Table 1 Patients’ characteristics at HAART initiation, Savannakhet, Lao PDR, 2003–2009

Age (years)

Median [IQR]

33 [29 – 38]

32 [27 – 37]

0.003

32 [28 – 38]

WHO clinical stage

Stage 4

316 (62.3%)

215 (53.1%)

< 0.001

531 (58.2%)

Stage 3

143 (28.2%)

117 (28.9%)

261 (28.6%)

Stage 2

35 (6.9%)

44 (10.9%)

79 (8.6%)

Stage 1

13 (2.6%)

29 (7.1%)

42 (4.6%)

CD4 cell count (cells/μL) ^b

Median [IQR]

41 [12 – 130]

65 [20 – 166]

0.002

49 [15 – 148]

< 50

236 (55.3%)

155 (44.7%)

391 (50.5%)

50-199

144 (33.7%)

133 (38.3%)

278 (35.9%)

≥ 200

47 (11.0%)

59 (17.0%)

106 (13.6%)

Body mass index (kg/m ² ) ^c

Median [IQR]

18.7 [17.1 – 20.7]

18.2 [16.4 – 20.5]

0.07

18.5 [16.8 – 20.6]

Haemoglobin level (g/dL) ^d

Median [IQR]

11.6 [9.9 – 13.2]

11.3 [9.6 – 12.7]

0.07

11.4 [9.7 – 13.1]